During the past decade, National Hospital Organization Nagasaki Medical Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 15 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Nagasaki Medical Center" #1 sponsor was "Pfizer" with 9 trials, followed by "Gilead Sciences" with 5 trials sponsored, "Takeda" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Nagasaki Medical Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Japan Blood Products Organization" with 1 trials as a collaborator, "Takeda Development Center Americas, Inc." with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Nagasaki Medical Center" are "Rheumatoid Arthritis" (3 trials), "Dravet Syndrome (DS)" (2 trials), "HBV" (2 trials), "Heart Failure" (2 trials) and "Lennox Gastaut Syndrome (LGS)" (2 trials). Many other conditions were trialed in "National Hospital Organization Nagasaki Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Nagasaki Medical Center" are "Drug" (29 trials), "Biological" (5 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Soticlestat" (3 trials), "Empagliflozin" (2 trials), "JNJ-56136379" (2 trials) and "JNJ-73763989" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Nagasaki Medical Center" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Hospital Organization Nagasaki Medical Center". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in National Hospital Organization Nagasaki Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Nagasaki Medical Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".